Refine by
Sars Cov 2 Articles & Analysis
224 news found
Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...
The project has the goal to develop a “Pan-protective SARS-CoV-2 vaccine” hoping to show protection against all past and future variant of concern of the Corona virus. ...
This novel detection kit offers a streamlined and efficient approach to identify the Alpha (B.1.1.7), Delta (B.1.617.2), and Kappa (B.1.617.1) variants of SARS-CoV-2. By accurately detecting these variants, healthcare professionals and researchers can make informed decisions regarding public health measures, treatment options, and vaccine ...
AI-Powered Design: CD ComputaBio's state-of-the-art AI algorithms analyze vast datasets of antibody structures and sequences to predict and design novel antibodies with exceptional specificity and affinity. 2. Precision Targeting: The technology allows for the precise targeting of disease-related molecules by understanding the intricate interactions between antibodies and ...
It has been validated to work with a range of viruses, including SARS-CoV-2, influenza, and other respiratory viruses. The resulting solution is a highly stable, potent, and low-viscosity liquid that can transport viruses from the site of collection to the laboratory. ...
Some of them are listed below: dotap chloride, transfectam, dlin-kc2-dma, peg2000-c-dmg, dc-cholesterol, 12-o-dioctadecyl-sn-glycerol, 12-dioleoyl-sn-glycero-3-succinate, cardiolipin series, heptaethylene glycol monomethyl ether, methoxy PEG ditetradecylamino, etc . SARS-CoV-2 Detection Raw MaterialsIn response to the demand for accurate and ...
The first phase of the project will explore the possibility that the dielectric-based technology can be tuned to detect inactivated, non-infectious SARS-CoV-2. The second phase will demonstrate that the transformative dielectric-based device can detect SARS-CoV-2 with specificity and can ...
ByAlertgy
Viral Vaccine Manufacturing to control pandemics: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) has created a global public health crisis. Therefore, urgency in the development of vaccines is of vital importance to control the pandemic and ...
ByNuvonis
The lead antigens will be selected iteratively and validated in preclinical studies against known betacoronaviruses that already pose a significant epidemic or pandemic risk, such as SARS-CoV, SARS-CoV-2 & MERS-CoV. If this innovative approach is proven to be successful, it may also be ...
This drug, produced in spirulina, contains an antibody cocktail for SARS-CoV-2, the virus that causes COVID-19. Funding from the BARDA Division of Research, Innovation, and Ventures (DRIVe) enabled the company to reformulate LMN-301, previously developed for oral delivery, and to evaluate its potential as an anti-viral therapeutic ...
In November 2021, the company was awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative of the SARS-CoV-2 / COVID-19 virus. ...
As part of the RubrYc transaction, the Company now wholly-owns, with no further financial commitments, its lead immune-oncology asset, IBIO-101; an IL-2 sparing anti-CD25 antibody aimed at depleting immunosuppressive regulatory T cells without interfering with T effector cell anti-tumor effects. ...
Target knockdown and safety results support continued clinical development Alnylam and Regeneron intend to initiate a Phase 2 study in late 2022 Detailed results to be presented at an upcoming medical congress CAMBRIDGE, Mass. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Sep. 15, 2022-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) announced today ...
Recently, Reetoo SARS-CoV-2 Antigen Rapid Self-test Kit (Colloidal Gold) received CE certification accredited by CeCert Sp. z o.o. and completed clinical validation in Vitalabo Laboratoria Medyczne Sp. z o.o. according to the latest EU guidance MDCG 2021-21 Guidance on performance evaluation of ...
To better help global epidemic prevention and control, Reetoo biotech has successively obtained the CE certificates of SARS-CoV-2 Antigen Rapid Self-test Kit and Monkeypox Virus Real Time PCR Kit in time. ...
The Toronto-based research reports a decrease of viral infectivity of 90% of SARS-CoV-2 patient samples using Ondine’s nasal antimicrobial photodynamic disinfection (aPDT), with 70% of patient samples completely inactivated from a single 5-minute treatment. The nose is the primary location for ...
– AUG. 29, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced the publication of safety and efficacy results from Phase 1 and Phase 2 clinical trials investigating its anti-SARS-CoV-2 vaccine candidate AV-COVID-19 that is made at point-of-care by third-party ...
As you may already know, PCR is a method to detect SARS-COV-2 virus, more specifically its nucleic acid. It is the “golden standard” of SARS-2 detection, as declared by the World Health Association (WHO). ...
Introduction: Sudden cardiac arrest (SCA), which causes more than half of all cardiovascular related deaths, can be regarded as a common massive global public health problem. Analyzing out-of-hospital cardiac arrest (OHCA) cases, one of the key components is automatic external defibrillators (AEDs). Aim: The aim of this study was to analyze the use and distribution of AEDs in Polish public ...
Prior studies indicate that high levels of IL-6 serve as an early indication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced hyperinflammation, disease severity, and multiorgan ...